Physician

Gladys Grace Tiwonge Kamanga-Sollo, MD

According to 2025 Medicare claims, Gladys Kamanga-Sollo, MD (NPI: 1003115536) practices physical medicine and rehabilitation in the Cape Girardeau, MO-IL market, with the plurality of this provider's patient population coming from Cape Girardeau, MO. This provider's primary affiliated billing organization is REGIONAL BRAIN & SPINE LLC (NPI: 1992753289; TIN: 201953477) and primary practice location at 63701-4556. Kamanga-Sollo is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and IRCCO (ACO ID: A2619), participating under the MSSP model.

Kamanga-Sollo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 32,248 HCPCS/CPT codes, and received $226,216 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 124 prescription claims across 27 beneficiaries totaling $14,345 in drug costs, led by Qulipta (Atogepant). 2017 DME data shows 12 claims. Open Payments data shows 64 records totaling $1,269. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $54,024 to $226,216. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $479 and ending at $14,345. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	271	654	$54,024
2016	493	2,312	$111,281
2017	420	7,306	$116,761
2018	384	5,627	$100,738
2019	412	12,070	$135,651
2020	331	17,021	$153,345
2021	277	12,747	$125,471
2022	357	22,292	$200,575
2023	301	26,805	$207,115
2024	270	32,248	$226,216

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	14	$479
2016	11	20	$2,851
2017	11	40	$522
2018	N/R	17	$5,573
2019	15	35	$641
2020	25	57	$1,286
2021	13	28	$1,170
2022	30	59	$669
2023	22	81	$5,273
2024	27	124	$14,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	13	$469
2017	N/R	12	$382
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	124	137	$142
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	34	46	$122
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	56	56	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	159	$86
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	152	309	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Qulipta	Atogepant	11	330	$11,311
Pregabalin	Pregabalin	14	600	$1,528
Baclofen	Baclofen	24	720	$222
Gabapentin	Gabapentin	23	930	$112
Rizatriptan	Rizatriptan Benzoate	12	360	$94

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,269	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gladys Grace Tiwonge Kamanga-Sollo, MD?

Tedicare shows public-source Medicare data for Gladys Grace Tiwonge Kamanga-Sollo, MD (NPI 1003115536), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gladys Grace Tiwonge Kamanga-Sollo, MD have ACO affiliation data?

Gladys Grace Tiwonge Kamanga-Sollo, MD is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616) and IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Gladys Grace Tiwonge Kamanga-Sollo, MD?

Gladys Grace Tiwonge Kamanga-Sollo, MD is linked to REGIONAL BRAIN & SPINE LLC (billing NPI 1992753289) in the available physician profile data.

Does Gladys Grace Tiwonge Kamanga-Sollo, MD have Open Payments data?

Gladys Grace Tiwonge Kamanga-Sollo, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.